Enterprise Dynamic
The clinical trial “A Randomized, Controlled, Open-label, Multicenter, Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Chlorogenic Acid for Injection in the Treatment of Recurrent G...
[View details]
The Third China BioMed Innovation and Investment Conference was held at the Suzhou BioBay Conference Center on September 18, 2018. At the conference, Jiuzhang Biotech Company presented a special repor...
[View details]
On May 19, 2018, Seminar on Phase II/III Clinical Trial of Chlorogenic Acid for Injection in Treating GBM organized by our company (Sponsor) was successfully completed.Based on data of chlorogenic aci...
[View details]
On 1 April 2018, a conference was held at Guangxi Building in Beijing to discuss the protocol of the single arm, open-label, multicenter, phase Ib/IIa clinical study for chlorogenic acid for injection...
[View details]
